Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2684 |
|
| Actual shortage: | 240 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2435 (91%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT ENALAPRIL | 16MG | TABLET | Resolved | 2023-06-19 | 2023-07-06 | 195646 |
| ACT ESCITALOPRAM ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2022-09-22 | 2023-06-09 | 169990 |
| ACT ESCITALOPRAM ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2022-09-22 | 2023-06-09 | 169995 |
| ACT ESCITALOPRAM ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2022-03-31 | 2022-06-17 | 157637 |
| ACT ESCITALOPRAM ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2019-11-28 | 2020-02-21 | 99971 |
| ACT ESCITALOPRAM ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2019-11-28 | 2020-02-21 | 99974 |
| ACT ESCITALOPRAM ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2021-04-29 | 2021-07-09 | 138282 |
| ACT ESCITALOPRAM ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2022-03-24 | 2022-05-05 | 157265 |
| TEVA-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2017-05-10 | 2018-07-30 | 9912 |
| ACT ETIDROCAL | 400MG 500MG | TABLET | Actual shortage | 2018-08-01 | 2019-02-21 | 57207 |
| ACT EXEMESTANE | 25MG | TABLET | Resolved | 2018-12-04 | 2019-03-14 | 68592 |
| ACT FAMCICLOVIR | 125MG | TABLET | Actual shortage | 2018-10-23 | 2018-10-23 | 65497 |
| ACT FAMCICLOVIR | 500MG | TABLET | Actual shortage | 2018-10-23 | 2018-10-23 | 65500 |
| ACT FAMCICLOVIR | 250MG | TABLET | Actual shortage | 2018-10-23 | 2018-10-23 | 65502 |
| ACT FAMCICLOVIR | 500MG | TABLET | Actual shortage | 2018-10-23 | 2018-10-23 | 65507 |
| ACT FLUCONAZOLE | 50MG | TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195530 |
| ACT FLUCONAZOLE | 100MG | TABLET | Resolved | 2023-06-19 | 2023-07-21 | 195551 |
| TEVA-FLUVOXAMINE | 50MG | TABLET | Resolved | 2023-07-18 | 2024-03-18 | 199092 |
| TEVA-LEVETIRACETAM | 500MG | TABLET | Resolved | 2017-05-10 | 2018-10-11 | 9922 |
| TEVA-LEVETIRACETAM | 750MG | TABLET | Resolved | 2017-05-10 | 2018-10-11 | 9939 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65020 |
| TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65023 |
| TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106133 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | To be discontinued | 2019-07-05 | 2019-07-05 | 88619 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |